Orexo AB (OSTO:ORX) Days Payable : 0.00 (As of Sep. 2024)

View and export this data going back to 2005. Start your Free Trial

What is Orexo AB Days Payable?

Orexo AB's average Accounts Payable for the three months ended in Sep. 2024 was kr0.0 Mil. Orexo AB's Cost of Goods Sold for the three months ended in Sep. 2024 was kr20.1 Mil. Hence, Orexo AB's Days Payable for the three months ended in Sep. 2024 was 0.00.

The historical rank and industry rank for Orexo AB's Days Payable or its related term are showing as below:

OSTO:ORX' s Days Payable Range Over the Past 10 Years
Min: 77.52 Med: 195.17 Max: 283.51
Current: 190.87

During the past 13 years, Orexo AB's highest Days Payable was 283.51. The lowest was 77.52. And the median was 195.17.

OSTO:ORX's Days Payable is ranked better than
82.88% of 952 companies
in the Drug Manufacturers industry
Industry Median: 85.205 vs OSTO:ORX: 190.87

Orexo AB's Days Payable stayed the same from Sep. 2023 (0.00) to Sep. 2024 (0.00). stayed the same

Orexo AB Days Payable Historical Data

The historical data trend for Orexo AB's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orexo AB Days Payable Chart

Orexo AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

167.81

268.19

222.52

241.55

252.99

Orexo AB Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Days Payable	Get a 7-Day Free Trial															-	165.70	250.42	-	-

Competitive Comparison of Orexo AB's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Orexo AB's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Orexo AB's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Orexo AB's Days Payable distribution charts can be found below:

* The bar in red indicates where Orexo AB's Days Payable falls into.

Orexo AB Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Orexo AB's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (86.6	+	36.5)	/	2 )	/	88.8	*	365
=	61.55					/	88.8	*	365
=	252.99

Orexo AB's Days Payable for the quarter that ended in Sep. 2024 is calculated as:

	Days Payable (Q: Sep. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2024 )	+	Accounts Payable (Q: Sep. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Sep. 2024 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	20.1	*	365 / 4
=	0					/	20.1	*	365 / 4
=	0.00

Orexo AB Days Payable Related Terms

Thank you for viewing the detailed overview of Orexo AB's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Orexo AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orexo AB (OSTO:ORX) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

ORXOY:USA ORXOF:USA C5G:Germany

Address

Virdings alle 32 A, P.O. Box 303, Uppsala, SWE, 75105

Website

https://www.orexo.com

Orexo AB has operations in Sweden and the United States. Operations are monitored and presented in the segments USA Pharma, Digital Therapeutics (DTx), and HQ & Pipeline. The majority is from the USA Pharma segment. Geographically, the majority is derived from the United States. USA Pharma includes the commercialization of fully owned pharmaceuticals in the United States market. Digital Therapeutics include the commercialization of Orexo's groundbreaking evidence-based digital therapeutics, mainly in the United States market, which is in an early development stage. HQ &Pipeline includes the Development of pharmaceuticals performed at Orexo's headquarters in Uppsala, Sweden.

Orexo AB Headlines

No Headlines